Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

Orthogonal Halogen-Bonding-Driven 3D Supramolecular Assembly of Right-Handed Synthetic Helical Peptides.

Teng P, Gray GM, Zheng M, Singh S, Li X, Wojtas L, van der Vaart A, Cai J.

Angew Chem Int Ed Engl. 2019 Jun 3;58(23):7778-7782. doi: 10.1002/anie.201903259. Epub 2019 Apr 30.

PMID:
30957356
2.

Challenges and Considerations When Balancing the Risks of Contaminants with the Benefits of Fruits and Vegetables for Infants and Toddlers.

Callen C, Bhatia J, Czerkies L, Klish WJ, Gray GM.

Nutrients. 2018 Oct 24;10(11). pii: E1572. doi: 10.3390/nu10111572.

3.

Hydrogen-Bonding-Driven 3D Supramolecular Assembly of Peptidomimetic Zipper.

Teng P, Niu Z, She F, Zhou M, Sang P, Gray GM, Verma G, Wojtas L, van der Vaart A, Ma S, Cai J.

J Am Chem Soc. 2018 May 2;140(17):5661-5665. doi: 10.1021/jacs.7b11997. Epub 2018 Apr 3.

PMID:
29590526
4.

One-Bead-Two-Compound Thioether Bridged Macrocyclic γ-AApeptide Screening Library against EphA2.

Shi Y, Challa S, Sang P, She F, Li C, Gray GM, Nimmagadda A, Teng P, Odom T, Wang Y, van der Vaart A, Li Q, Cai J.

J Med Chem. 2017 Nov 22;60(22):9290-9298. doi: 10.1021/acs.jmedchem.7b01280. Epub 2017 Nov 14.

5.

Molecular dynamics simulations and molecular flooding studies of the retinoid X-receptor ligand binding domain.

Gray GM, Ma N, Wagner CE, van der Vaart A.

J Mol Model. 2017 Mar;23(3):98. doi: 10.1007/s00894-017-3260-9. Epub 2017 Mar 1.

PMID:
28251414
6.

Secondary Structure Adopted by the Gly-Gly-X Repetitive Regions of Dragline Spider Silk.

Gray GM, van der Vaart A, Guo C, Jones J, Onofrei D, Cherry BR, Lewis RV, Yarger JL, Holland GP.

Int J Mol Sci. 2016 Dec 2;17(12). pii: E2023.

7.

Computer Simulations of the Retinoid X Receptor: Conformational Dynamics and Allosteric Networks.

van der Vaart A, Lorkowski A, Ma N, Gray GM.

Curr Top Med Chem. 2017;17(6):731-741. Review.

PMID:
27320334
8.

An Overview of Occupational Risks From Climate Change.

Applebaum KM, Graham J, Gray GM, LaPuma P, McCormick SA, Northcross A, Perry MJ.

Curr Environ Health Rep. 2016 Mar;3(1):13-22. doi: 10.1007/s40572-016-0081-4. Review.

PMID:
26842343
9.

Importance of β2-β3 Loop Motion for the Increased Binding and Decreased Selectivity of the ΔLL Mutant of the Human Papillomavirus Type 6 E2 Protein.

Gray GM, van der Vaart A.

Biochemistry. 2015 Aug 11;54(31):4918-26. doi: 10.1021/acs.biochem.5b00433. Epub 2015 Jul 30.

PMID:
26169609
10.

Modeling, synthesis, and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene) and (E)-3-(3-(1,2,3,4-tetrahydro-1,1,4,4,6-pentamethylnaphthalen-7-yl)-4-hydroxyphenyl)acrylic acid (CD3254).

Jurutka PW, Kaneko I, Yang J, Bhogal JS, Swierski JC, Tabacaru CR, Montano LA, Huynh CC, Jama RA, Mahelona RD, Sarnowski JT, Marcus LM, Quezada A, Lemming B, Tedesco MA, Fischer AJ, Mohamed SA, Ziller JW, Ma N, Gray GM, van der Vaart A, Marshall PA, Wagner CE.

J Med Chem. 2013 Nov 14;56(21):8432-54. doi: 10.1021/jm4008517. Epub 2013 Nov 1.

11.

Synthesis, linear and nonlinear optical properties of phosphonato-substituted bithiophenes derived from 2,2'-biphenol.

Freeman JL, Zhao Q, Zhang Y, Wang J, Lawson CM, Gray GM.

Dalton Trans. 2013 Oct 21;42(39):14281-97. doi: 10.1039/c3dt51499d.

PMID:
23959099
12.

The work environment disability-adjusted life year for use with life cycle assessment: a methodological approach.

Scanlon KA, Gray GM, Francis RA, Lloyd SM, LaPuma P.

Environ Health. 2013 Mar 6;12:21. doi: 10.1186/1476-069X-12-21.

13.

Policy: Rethink chemical risk assessments.

Gray GM, Cohen JT.

Nature. 2012 Sep 6;489(7414):27-8. doi: 10.1038/489027a. No abstract available.

PMID:
22955594
14.

Modeling, synthesis and biological evaluation of potential retinoid X receptor-selective agonists: novel halogenated analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene).

Furmick JK, Kaneko I, Walsh AN, Yang J, Bhogal JS, Gray GM, Baso JC, Browder DO, Prentice JL, Montano LA, Huynh CC, Marcus LM, Tsosie DG, Kwon JS, Quezada A, Reyes NM, Lemming B, Saini P, van der Vaart A, Groy TL, Marshall PA, Jurutka PW, Wagner CE.

ChemMedChem. 2012 Sep;7(9):1551-66.

15.

Syntheses, X-ray crystal structures, and optical, fluorescence, and nonlinear optical characterizations of diphenylphosphino-substituted bithiophenes.

Zhao Q, Freeman JL, Wang J, Zhang Y, Hamilton TP, Lawson CM, Gray GM.

Inorg Chem. 2012 Feb 20;51(4):2016-30. doi: 10.1021/ic201309k. Epub 2012 Feb 9.

PMID:
22320257
16.

Syntheses, and optical, fluorescence, and nonlinear optical characterization of phosphine-substituted terthiophenes.

Zhao Q, Wang J, Freeman JL, Murphy-Jolly M, Wright AM, Scardino DJ, Hammer NI, Lawson CM, Gray GM.

Inorg Chem. 2011 Mar 7;50(5):2015-27. doi: 10.1021/ic101624y.

PMID:
21361383
17.

Dioxin toxicity.

Cohen JT, Gray GM.

Risk Anal. 2010 Oct;30(10):1457-8. doi: 10.1111/j.1539-6924.2010.01504.x. No abstract available.

PMID:
21039696
18.

Differential diagnosis of torticollis: a case report.

Gray GM, Tasso KH.

Pediatr Phys Ther. 2009 Winter;21(4):369-74. doi: 10.1097/PEP.0b013e3181beca44.

PMID:
19923978
19.

A food-grade enzyme preparation with modest gluten detoxification properties.

Ehren J, Morón B, Martin E, Bethune MT, Gray GM, Khosla C.

PLoS One. 2009 Jul 21;4(7):e6313. doi: 10.1371/journal.pone.0006313.

20.

A non-human primate model for gluten sensitivity.

Bethune MT, Borda JT, Ribka E, Liu MX, Phillippi-Falkenstein K, Jandacek RJ, Doxiadis GG, Gray GM, Khosla C, Sestak K.

PLoS One. 2008 Feb 20;3(2):e1614. doi: 10.1371/journal.pone.0001614.

21.

Toxicology. Transforming environmental health protection.

Collins FS, Gray GM, Bucher JR.

Science. 2008 Feb 15;319(5865):906-7. doi: 10.1126/science.1154619. No abstract available.

22.

Enhancement of dietary protein digestion by conjugated bile acids.

Gass J, Vora H, Hofmann AF, Gray GM, Khosla C.

Gastroenterology. 2007 Jul;133(1):16-23. Epub 2007 Apr 14.

PMID:
17631126
24.

Measured concentrations of VOCs in several non-residential microenvironments in the United States.

Loh MM, Houseman EA, Gray GM, Levy JI, Spengler JD, Bennett DH.

Environ Sci Technol. 2006 Nov 15;40(22):6903-11.

PMID:
17153993
25.

Rational design of combination enzyme therapy for celiac sprue.

Siegel M, Bethune MT, Gass J, Ehren J, Xia J, Johannsen A, Stuge TB, Gray GM, Lee PP, Khosla C.

Chem Biol. 2006 Jun;13(6):649-58.

26.

Effect of barley endoprotease EP-B2 on gluten digestion in the intact rat.

Gass J, Vora H, Bethune MT, Gray GM, Khosla C.

J Pharmacol Exp Ther. 2006 Sep;318(3):1178-86. Epub 2006 Jun 6.

PMID:
16757540
27.

A quantitative analysis of fish consumption and stroke risk.

Bouzan C, Cohen JT, Connor WE, Kris-Etherton PM, Gray GM, König A, Lawrence RS, Savitz DA, Teutsch SM.

Am J Prev Med. 2005 Nov;29(4):347-52.

PMID:
16242601
28.

A quantitative analysis of fish consumption and coronary heart disease mortality.

König A, Bouzan C, Cohen JT, Connor WE, Kris-Etherton PM, Gray GM, Lawrence RS, Savitz DA, Teutsch SM.

Am J Prev Med. 2005 Nov;29(4):335-46.

PMID:
16242600
29.

A quantitative risk-benefit analysis of changes in population fish consumption.

Cohen JT, Bellinger DC, Connor WE, Kris-Etherton PM, Lawrence RS, Savitz DA, Shaywitz BA, Teutsch SM, Gray GM.

Am J Prev Med. 2005 Nov;29(4):325-34.

PMID:
16242599
30.

Putative efficacy and dosage of prolyl endopeptidase for digesting and detoxifying gliadin peptides.

Khosla C, Gray GM, Sollid LM.

Gastroenterology. 2005 Oct;129(4):1362-3; author reply 1363. No abstract available.

PMID:
16230098
31.

Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.

Shan L, Qiao SW, Arentz-Hansen H, Molberg Ø, Gray GM, Sollid LM, Khosla C.

J Proteome Res. 2005 Sep-Oct;4(5):1732-41.

32.

Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue.

Pyle GG, Paaso B, Anderson BE, Allen DD, Marti T, Li Q, Siegel M, Khosla C, Gray GM.

Clin Gastroenterol Hepatol. 2005 Jul;3(7):687-94.

PMID:
16206502
33.

Low-dose gluten challenge in celiac sprue: malabsorptive and antibody responses.

Pyle GG, Paaso B, Anderson BE, Allen D, Marti T, Khosla C, Gray GM.

Clin Gastroenterol Hepatol. 2005 Jul;3(7):679-86.

PMID:
16206501
34.

Surface characterization of untreated and solvent-extracted rice straw.

Inglesby MK, Gray GM, Wood DF, Gregorski KS, Robertson RG, Sabellano GP.

Colloids Surf B Biointerfaces. 2005 Jun 25;43(2):83-94.

PMID:
15922577
35.

Prolyl endopeptidase-mediated destruction of T cell epitopes in whole gluten: chemical and immunological characterization.

Marti T, Molberg O, Li Q, Gray GM, Khosla C, Sollid LM.

J Pharmacol Exp Ther. 2005 Jan;312(1):19-26. Epub 2004 Sep 9.

PMID:
15358813
36.

Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue.

Shan L, Marti T, Sollid LM, Gray GM, Khosla C.

Biochem J. 2004 Oct 15;383(Pt 2):311-8.

37.

Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo.

Piper JL, Gray GM, Khosla C.

J Pharmacol Exp Ther. 2004 Oct;311(1):213-9. Epub 2004 May 13.

PMID:
15143130
38.

A role for bacteria in celiac disease?

Sollid LM, Gray GM.

Am J Gastroenterol. 2004 May;99(5):905-6.

PMID:
15128358
39.

Food safety: risk assessment methodology and decision-making criteria.

Brock WJ, Rodricks JV, Rulis A, Dellarco VL, Gray GM, Lane RW.

Int J Toxicol. 2003 Nov-Dec;22(6):435-51.

PMID:
14680991
40.

The effect of different tumor groupings on findings of anticarcinogenic responses in long-term rodent bioassays.

Gray GM, Huang H, Linkov I, Polkanov M, Wilson R.

Regul Toxicol Pharmacol. 2002 Oct;36(2):139-48. Review.

PMID:
12460748
41.

Dealing with the dangers of fear: the role of risk communication.

Gray GM, Ropeik DP.

Health Aff (Millwood). 2002 Nov-Dec;21(6):106-16.

PMID:
12442846
42.

Structural basis for gluten intolerance in celiac sprue.

Shan L, Molberg Ø, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM, Khosla C.

Science. 2002 Sep 27;297(5590):2275-9.

43.

Intestinal digestive resistance of immunodominant gliadin peptides.

Hausch F, Shan L, Santiago NA, Gray GM, Khosla C.

Am J Physiol Gastrointest Liver Physiol. 2002 Oct;283(4):G996-G1003.

44.
45.
46.

Sucrase-alpha-dextrinase in the spontaneously diabetic BioBreed Wistar rat: altered intracellular carbohydrate processing.

Najjar SM, Broyart JP, Hampp LT, Gray GM.

J Cell Biochem. 2001 Mar 26;81(2):252-61.

PMID:
11241665
47.

Intestinal aminooligopeptidase in diabetic BioBreed rat: altered posttranslational processing and trafficking.

Najjar SM, Broyart JP, Hampp LT, Gray GM.

Am J Physiol Gastrointest Liver Physiol. 2001 Jan;280(1):G104-12.

49.

Rodent cancer bioassays - is body weight depression hormetic?

Gray GM.

Hum Exp Toxicol. 2000 Jun;19(6):332-4. Review. No abstract available.

PMID:
10962500
50.

Correlations among tumor types in mouse cancer bioassays: liver adenomas, liver carcinomas, leukemias and lymphomas.

Linkov I, Polkanov M, Shagiakhmetov A, Wilson R, Gray GM.

Toxicol Ind Health. 2000 Jan;16(1):16-40.

PMID:
10798383

Supplemental Content

Support Center